RecruitingNCT04908319
Hepatic Histopathology in Urea Cycle Disorders
Studying Ornithine transcarbamylase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Baylor College of Medicine
- Principal Investigator
- Lindsay Burrage, MD, PhDBaylor College of Medicine
- Enrollment
- 70 enrolled
- Eligibility
- All sexes
- Timeline
- 2022 – 2026
Study locations (2)
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Baylor College of Medicine, Houston, Texas, United States
Collaborators
Children's National Research Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04908319 on ClinicalTrials.govOther trials for Ornithine transcarbamylase deficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06805695Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)iECURE, Inc.
- RECRUITINGPHASE2NCT06488313A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCDArcturus Therapeutics, Inc.
- RECRUITINGPHASE1, PHASE2NCT06255782An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC DeficiencyiECURE, Inc.
- RECRUITINGPHASE1, PHASE2NCT05092685Halting Ornithine Transcarbamylase Deficiency With Recombinant AAV in ChildrEnUniversity College, London
- ACTIVE NOT RECRUITINGPHASE3NCT05345171Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) DeficiencyUltragenyx Pharmaceutical Inc
- ACTIVE NOT RECRUITINGNCT04612764Liver Disease in Urea Cycle DisordersBaylor College of Medicine
- ACTIVE NOT RECRUITINGNCT03636438Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC DeficiencyUltragenyx Pharmaceutical Inc